Trial intelligence / Profile preview

Herbal cream versus topical mometasone for atopic dermatitis

IRCT20211216053428N1Phase 3Completed

Sponsor
Vice Chancellor for Research of Isfahan University of Medical Sciences
Start
Jan 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of mometasone in atopic dermatitis (AD) (2 arms), sponsored by Vice Chancellor for Research of Isfahan University of Medical Sciences. Started Jan 2022; status: completed.

02

Drugs

mometasone
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on IRCT20211216053428N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211216053428N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call